Alpha-synuclein spreading in Parkinson's disease

被引:130
|
作者
Recasens, Ariadna [1 ]
Dehay, Benjamin [2 ,3 ]
机构
[1] Ctr Networked Biomed Res Neurodegenerat Dis, Neurodegenerat Dis Res Grp, Vall dHebron Res Inst, Barcelona, Spain
[2] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33076 Bordeaux, France
[3] Ctr Natl Rech Sci, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France
来源
关键词
alpha-synuclein; spreading; aggregation; Parkinson disease; neurodegenerative diseases; NEURONAL CELL-DEATH; COMPLEX-I; TRANSGENIC MICE; NEURODEGENERATIVE-DISEASES; MEMBRANE ASSOCIATION; DOPAMINERGIC-NEURONS; ALA53THR MUTATION; PATHOLOGY SPREAD; BRAIN-REGIONS; TRANSMISSION;
D O I
10.3389/fnana.2014.00159
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Formation and accumulation of misfolded protein aggregates are a central hallmark of several neurodegenerative diseases. In Parkinson's disease (PD), the aggregation-prone protein alpha-synuclein (alpha-syn) is the culprit. In the past few years, another piece of the puzzle has been added with data suggesting that a-syn may self-propagate, thereby contributing to the progression and extension of PD. Of particular importance, it was the seminal observation of Lewy bodies (LB), a histopathological signature of PD, in grafted fetal dopaminergic neurons in the striatum of PD patients. Consequently, these findings were a conceptual breakthrough, generating the "host to graft transmission" hypothesis, also called the "prion-like hypothesis." Several in vitro and in vivo studies suggest that a-syn can undergo a toxic templated conformational change, spread from cell to cell and from region to region, and initiate the formation of "LB like aggregates," contributing to the PD pathogenesis. Here, we will review and discuss the current knowledge for such a putative mechanism on the orlon-like nature of a-syn, and discuss about the proper use of the term orlon-like.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9
  • [2] Alpha-synuclein and Parkinson's disease
    Lücking, CB
    Brice, A
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (13-14) : 1894 - 1908
  • [3] Alpha-synuclein and Parkinson's disease
    C. B. Lücking
    A. Brice*
    Cellular and Molecular Life Sciences CMLS, 2000, 57 : 1894 - 1908
  • [4] alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology
    Sibylle E. Eisbach
    Tiago F. Outeiro
    Journal of Molecular Medicine, 2013, 91 : 693 - 703
  • [5] alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology
    Eisbach, Sibylle E.
    Outeiro, Tiago F.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (06): : 693 - 703
  • [6] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428
  • [7] Role of Alpha-Synuclein in Parkinson's Disease
    Link, Tina
    Maraghi, Sophie
    Reddy, Megan
    Sheth, Heli
    Stark, Kaylan
    Vijay, Varun
    FASEB JOURNAL, 2021, 35
  • [8] Peripheral Alpha-Synuclein and Parkinson's Disease
    Olanow, C. Warren
    Wakeman, Dustin R.
    Kordower, Jeffrey H.
    MOVEMENT DISORDERS, 2014, 29 (08) : 963 - 966
  • [9] Transmission of alpha-synuclein in Parkinson’s disease
    Virginia M-Y Lee
    Molecular Neurodegeneration, 8 (Suppl 1)
  • [10] Alpha-Synuclein as a Biomarker for Parkinson's Disease
    Atik, Anzari
    Stewart, Tessandra
    Zhang, Jing
    BRAIN PATHOLOGY, 2016, 26 (03) : 410 - 418